On Air Now

Current Show

Early Morning Journal   5:30 AM - 6:00 AM

The latest information to get your morning going on the Early Morning Journal

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
43° Feels Like: 43°
Wind: E 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 71°

Tonight

Clear 46°

Tomorrow

Sunny 72°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Novartis's smokers' cough treatment gets European nod

ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday the European Commission had approved its Seebri Breezhaler as a once-daily treatment for adult patients with chronic obstructive pulmonary disease, more commonly known as smoker's cough, in the European Union.

Trials showed that the treatment significantly improved lung function over the first four hours after morning dosing when compared to placebo, and that this benefit was sustained for 24 hours over a 52-week period, Novartis said.

The group said the treatment will be available to physicians and patients in some European Union markets by year end.

Deutsche Bank has estimated peak sales for Seebri Breezhaler at some $500 million.

(Reporting by Martin de Sa'Pinto)

Comments